Table 1.
Women's Characteristics at Start of Antiretroviral Therapy
| Characteristic | Women by Pregnancy and Breastfeeding Status at Start of ART, No. (%)a |
|||
|---|---|---|---|---|
| Pregnant (Option B+) (n = 4248; 56.9%) | Breastfeeding (Option B+) (n = 1614; 21.6%) | Not Pregnant or Breastfeeding (n = 1605; 21.5%) | Total (n = 7467; 100.0%) | |
| Age group | ||||
| 15–19 y | 279 (6.6) | 79 (4.9) | 48 (3.0) | 406 (5.4) |
| 20–24 y | 958 (22.6) | 360 (22.3) | 169 (10.5) | 1487 (19.9) |
| 25–29 y | 1731 (40.7) | 646 (40.0) | 424 (26.4) | 2801 (37.5) |
| ≥30 y | 1280 (30.1) | 529 (32.8) | 964 (60.1) | 2773 (37.1) |
| Age, median (IQR), y | 28 (24–32) | 28 (24–32) | 33 (27–39) | 29 (24–33) |
| Year of ART initiation | ||||
| 2011 | 516 (12.1) | 495 (30.7) | 248 (15.5) | 1259 (16.9) |
| 2012 | 2236 (52.6) | 803 (49.8) | 475 (29.6) | 3514 (47.1) |
| 2013 | 1496 (35.2) | 316 (19.6) | 882 (55.0) | 2694 (36.1) |
| WHO clinical stage | ||||
| 1 | 4187 (98.6) | 1435 (88.9) | 369 (23.0) | 5991 (80.2) |
| 2 | 38 (0.9) | 87 (5.4) | 169 (10.5) | 294 (3.9) |
| 3 | 15 (0.4) | 1 (0.1) | 749 (46.7) | 765 (10.2) |
| 4 | 8 (0.2) | 0 (0.0) | 206 (12.8) | 214 (2.9) |
| Unknown | 0 (0.0) | 91 (5.6) | 112 (7.0) | 203 (2.7) |
| Facility type | ||||
| Central hospital | 462 (10.9) | 180 (11.2) | 464 (28.9) | 1106 (14.8) |
| District hospital | 2546 (59.9) | 858 (53.2) | 723 (45.0) | 4127 (55.3) |
| Mission hospital | 349 (8.2) | 267 (16.5) | 180 (11.2) | 796 (10.7) |
| Health center | 891 (21.0) | 309 (19.1) | 238 (14.8) | 1438 (19.3) |
Abbreviations: ART, antiretroviral therapy; IQR, interquartile range; WHO, World Health Organization.
a Data represent No. (%) of women unless otherwise indicated.